Literature DB >> 2157783

Modification of exercise-aggravated coxsackievirus B3 murine myocarditis by T lymphocyte suppression in an inbred model.

A E Cabinian1, R J Kiel, F Smith, K L Ho, R Khatib, M P Reyes.   

Abstract

The effects of T lymphocyte suppression on coxsackievirus B3 (CB3) myocarditis and its augmentation by exercise were determined in this study. Three-week-old male C3H/HeN mice were divided into four groups. Group 1 mice were infected intraperitoneally (IP) on day 0 with CB3 10(2.5) TCID50, were made to swim daily from days 1 to 9, and were immunosuppressed with daily doses of cyclosporine A (25 mg/kg IP) from days -2 to 8, plus 0.1 ml antithymocyte 1.2 IgG 2a monoclonal antibody IP on day 0. Mice in group 2 were infected and made to swim daily from days 1 to 9. Mice in group 3 were infected and immunosuppressed as outlined. Mice in group 4 were infected IP with CB3. Mortality rates during the acute phase of infection (days 1 to 9) were as follows: group 1, 4% (1/25); group 2, 52% (13/25); groups 3 and 4, 0. Overall mortality rates through day 21 were as follows: group 1, 67% (17/25); group 2, 72% (18/25); group 3, 40% (10/25); and group 4, 4% (1/25). Mean viral titers in serum were highest in the immunosuppressed groups throughout the study. Myocardial viral titers (mean log10 TCID50) were higher in group 2 mice than in group 1 on days 6 (10(6.9) vs 10(4.6)) and 9 (10(8.4) vs 10(7)); however, these titers peaked in group 1 mice on day 13 (10(9.7)). Myocardial inflammation, necrosis, and mean heart weight/body weight ratios were lower in group 1 compared with group 2 on days 6 and 9 but were maximal on day 13 in group 1. Neutralizing antibody titers were lower in immunosuppressed mice on days 6 and 9; however, a rebound increase occurred on day 13.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157783

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

Review 1.  Cardiac Imaging in the Athlete: Shrinking the "Gray Zone".

Authors:  Mario R Caruso; Lohit Garg; Matthew W Martinez
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-02-03

Review 2.  Myocarditis.

Authors:  Leslie T Cooper
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

3.  Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma delta + T-cell receptor.

Authors:  S A Huber; A Mortensen; G Moulton
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 4.  Myocarditis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Prog Cardiovasc Dis       Date:  2010 Jan-Feb       Impact factor: 8.194

5.  Myocardial remodelling and tissue characterisation by cardiovascular magnetic resonance (CMR) in endurance athletes.

Authors:  Sandra Pujadas; Maite Doñate; Chi-Hion Li; Soraya Merchan; Ana Cabanillas; Xavier Alomar; Guillem Pons-Llado; Ricard Serra-Grima; Francesc Carreras
Journal:  BMJ Open Sport Exerc Med       Date:  2018-10-25

6.  Sports participation and myocarditis: Influence of sport types on disease severity.

Authors:  Robin Bouchau; Eve Cariou; Antoine Deney; Slimane Belaid; Romain Itier; Virginie Blanchard; Pauline Fournier; Alexandre Duparc; Michel Galinier; Didier Carrié; Olivier Lairez; Yoan Lavie-Badie
Journal:  Int J Cardiol Heart Vasc       Date:  2021-10-26

Review 7.  Myocardial fibrosis in athletes-Current perspective.

Authors:  Łukasz A Małek; Chiara Bucciarelli-Ducci
Journal:  Clin Cardiol       Date:  2020-03-19       Impact factor: 2.882

Review 8.  Infection in athletes.

Authors:  I K Brenner; P N Shek; R J Shephard
Journal:  Sports Med       Date:  1994-02       Impact factor: 11.136

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.